Revenue declined significantly year-over-year, driven by weakness in the Thermal Barrier segment. The company posted a substantial net loss due to restructuring, impairment, and disposal charges, while Adjusted EBITDA turned negative.

Aspen Aerogels posted a decline in revenue and adjusted EBITDA in Q3 2025, but narrowed its net loss compared to the prior year. The company highlighted a major PyroThin® award in Europe and expects energy industrial growth in 2026.

Aspen Aerogels experienced a challenging second quarter in 2025 with total revenue of $78.0 million, a decrease from the prior year. Despite a net loss of $9.1 million, the company showed significant improvement in gross margins at 32% and nearly doubled its Adjusted EBITDA quarter-over-quarter to $9.7 million, driven by cost structure reductions and strategic streamlining efforts.

Aspen Aerogels reported a significant net loss in Q1 2025, primarily due to a large impairment charge related to a planned manufacturing plant. Revenue decreased year-over-year, while adjusted EBITDA also saw a decline. The company highlighted a new PyroThin award and positive operating cash flow.

Aspen Aerogels, Inc. achieved record revenues of $123.1 million in Q4 2024, a 46% year-over-year increase, with net income reaching $11.4 million and Adjusted EBITDA at $22.7 million, demonstrating strong operational performance and profitability.

Aspen Aerogels reported a revenue of $117.3 million for Q3 2024, a significant increase compared to $60.8 million in Q3 2023. The company's gross margins stood at 42%, with Adjusted EBITDA margins at 22%. They have increased their 2024 financial outlook to $450 million in revenue, $9 million in net income, and $90 million in Adjusted EBITDA.

Aspen Aerogels reported record quarterly revenues of $117.8 million, a 145% increase year-over-year, and a net income of $16.8 million, compared to a net loss in the same quarter last year. The company's adjusted EBITDA was $28.9 million, demonstrating significant operating leverage. Aspen has increased its 2024 revenue and profitability outlook for the second consecutive quarter.

Aspen Aerogels reported a strong first quarter of 2024, with a 37% increase in revenue to $94.5 million compared to $45.6 million in Q1 2023. The company's Adjusted EBITDA was $12.9 million, a significant improvement from $(13.9) million in the same period last year. They are raising 2024 baseline Adjusted EBITDA outlook by 83% and expecting positive net income for 2024.

Aspen Aerogels reported a strong fourth quarter in 2023, with record revenues of $84.2 million, a gross margin of 35%, and an adjusted EBITDA of $9.1 million. The company saw improvements in operating income and net loss compared to the previous year. They also provided a financial outlook for 2024, projecting revenue of at least $350 million and adjusted EBITDA of at least $30 million.

Aspen Aerogels reported record revenue of $60.8 million in Q3 2023, driven by a 160% quarter-over-quarter increase in PyroThin® revenues, reaching $32.8 million. The company's gross profit margins improved to 23%, a 6-percentage point increase from the previous quarter. Net loss was $13.1 million, and adjusted EBITDA was $(7.3) million, showing improvements compared to the previous year.

Aspen Aerogels reported Q2 2023 revenue of $48.2 million, compared to $45.6 million in the second quarter of last year. Net loss was $15.4 million, compared to a net loss of $24.1 million in the second quarter of last year. The company is reducing projected 2023 Net Loss outlook by $17 million.

Aspen Aerogels reported revenue of $45.6 million, a 19% increase year-over-year. The company's net loss was $16.8 million, an improvement compared to the previous year's $19.5 million loss. The company was awarded a PyroThin® contract for a European EV commercial truck program and is executing a contract manufacturing strategy to increase capacity.

Aspen Aerogels reported a 90% year-over-year increase in quarterly revenue, driving annual revenues to $180 million, a 48% increase. The company's Q4 net loss was $9.6 million, an improvement from the previous year's $16.4 million. The company also executed a successful equity offering and secured a lending commitment from General Motors.

Aspen Aerogels, Inc. reported a net loss of $29.6 million for the third quarter of 2022, compared to a net loss of $7.8 million in the third quarter of 2021. Total revenue for the third quarter of 2022 was $36.7 million, compared to $30.4 million in the third quarter last year. The company saw record PyroThin® thermal barrier revenue in Q3, although it was less than expected.

Aspen Aerogels, Inc. announced financial results for the second quarter of 2022, reporting a total revenue of $45.6 million, a 44% increase compared to the previous year. However, the company experienced a net loss of $24.1 million, and an adjusted EBITDA of $(18.3) million, reflecting increased investments in personnel, infrastructure, and related activities.

Aspen Aerogels, Inc. reported a 37% year-over-year increase in total revenue for Q1 2022, reaching $38.4 million. The company strengthened its balance sheet through a $150.0 million investment from Koch Strategic Platforms and $23.6 million raised via an At-the-Market equity offering. However, the net loss increased to $19.5 million, compared to $6.3 million in the same quarter last year.

Aspen Aerogels reported a revenue increase of 21% for the full year 2021, driven by initial revenues in the electric vehicle market and recovery in the energy infrastructure market. However, the company experienced a net loss for both the quarter and the full year, impacted by COVID-related challenges and increased investments in personnel and infrastructure.

Aspen Aerogels reported a 26% increase in total revenue to $30.4 million for the third quarter of 2021, driven by a post-COVID recovery in the maintenance-related business. However, the company experienced a net loss of $7.8 million, which was attributed to planned investments in personnel, infrastructure, and related activities to support their PyroThin thermal barrier and carbon aerogel battery materials businesses.

Aspen Aerogels' total revenue for the second quarter was $31.7 million, a 29% increase compared to $24.6 million in the second quarter last year. The company's net loss was $6.7 million, compared to a net loss of $5.7 million in the second quarter of 2020.

Aspen Aerogels reported a slight decrease in revenue for Q1 2021, with $28.1 million compared to $28.4 million in Q1 2020. The company experienced a net loss of $6.3 million, which is higher than the $3.2 million loss in the same quarter last year. Despite COVID-19 impacts, strong LNG market demand partially offset declines. Investments in e-mobility initiatives contributed to decreased gross profit and Adjusted EBITDA.

Aspen Aerogels reported a decrease in revenue for the fourth quarter, from $46.5 million to $23.0 million. The company experienced a net loss of $6.2 million, compared to a net loss of $1.0 million in the fourth quarter of 2019. The company is focusing on leveraging its aerogel technology platform into high-value markets, including electric vehicles.

Aspen Aerogels reported a decrease in revenue and an increase in net loss for the third quarter of 2020, impacted by COVID-19. However, the company also announced a major EV contract award.

Aspen Aerogels reported a 17% decrease in revenue for Q2 2020 compared to the previous year, primarily due to reduced subsea project work and the impact of COVID-19 on the maintenance business. Despite the revenue decline, the company saw year-over-year growth in on-shore project work, driven by strong demand in the LNG market. Aspen is making strides in leveraging its aerogel technology platform within the electric vehicle market.

Aspen Aerogels reported a revenue increase to $28.4 million compared to $27.9 million in the first quarter last year. The company's net loss improved to $3.2 million, compared to a net loss of $6.0 million in the first quarter of 2019. Adjusted EBITDA for the first quarter was $0.5 million, an increase from $(2.6) million in the previous year.

Aspen Aerogels, Inc. announced financial results for the fourth quarter and full year 2019. The company's total revenue for the fourth quarter was $46.5 million, compared to $35.7 million in the fourth quarter last year. The fourth quarter net loss was $1.0 million, compared to a net loss of $14.1 million in the fourth quarter of 2018.